@ayyadhury Thanks @ayyadhury Here is a related paper from our friends at Texas A&M and @HeimbergerAmy https://t.co/NvjmJVtu3V
RT @NeurosurgeryNM: Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma https://t.co/CQ4L6HTRiG #ne…
RT @NeurosurgeryNM: Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma https://t.co/CQ4L6HTRiG #ne…
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma https://t.co/CQ4L6HTRiG #neurosurgery #neuroonc #btsm
Possible viable treatment for human brain cancer https://t.co/zFRKVcBbaO https://t.co/xVQxlBXwOm https://t.co/OA6DAAPLvD
RT @CCR_AACR: Phase 1 Study: STING agonist in dogs with glioblastoma. https://t.co/0Vw0IY03aj https://t.co/CcwNhSjFbM
RT @CCR_AACR: Phase 1 Study: STING agonist in dogs with glioblastoma. https://t.co/0Vw0IY03aj https://t.co/CcwNhSjFbM
Phase 1 Study: STING agonist in dogs with glioblastoma. https://t.co/0Vw0IY03aj https://t.co/CcwNhSjFbM
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma https://t.co/AlLItllt9a
RT @NeurosurgeryNM: Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine #Glioblastoma https://t.co/lq3kyZdz2g #G…
RT @NeurosurgeryNM: Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine #Glioblastoma https://t.co/lq3kyZdz2g #G…
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine #Glioblastoma https://t.co/lq3kyZdz2g #GBM #Neuoonc #neuro
RT @SBAmin: Great to see this paper on early clinical trials in dogs with spontaneous glioma (n=6) from our friends at @TAMU and @Northwest…
RT @SBAmin: Great to see this paper on early clinical trials in dogs with spontaneous glioma (n=6) from our friends at @TAMU and @Northwest…
RT @SBAmin: Great to see this paper on early clinical trials in dogs with spontaneous glioma (n=6) from our friends at @TAMU and @Northwest…
Great to see this paper on early clinical trials in dogs with spontaneous glioma (n=6) from our friends at @TAMU and @NorthwesternU @HeimbergerAmy https://t.co/U10kBwOnft
RT @BrainTumorInst: #ICYMI, a segment featuring @HeimbergerAmy & her research with @CraigHorbinski aired on @WGNTV: https://t.co/9afKBdNnwk…
RT @BrainTumorInst: #ICYMI, a segment featuring @HeimbergerAmy & her research with @CraigHorbinski aired on @WGNTV: https://t.co/9afKBdNnwk…
#ICYMI, a segment featuring @HeimbergerAmy & her research with @CraigHorbinski aired on @WGNTV: https://t.co/9afKBdNnwk. In this segment, she talks about recent findings published in @CCR_AACR: https://t.co/Z2wVlg9zpY that show promise for treating bot
RT @NeurosurgeryNM: STING agonists demonstrate signals of response in #dogs with spontaneously arising #glioblastoma https://t.co/o65CELvi…
STING agonists demonstrate signals of response in #dogs with spontaneously arising #glioblastoma https://t.co/o65CELvixy
RT @recherche_anima: 🙏🤞 #Glioblastoma: an immunotherapy protocol (intratumoral injection of STING agonists) stimulates the immune response…
🙏🤞 #Glioblastoma: an immunotherapy protocol (intratumoral injection of STING agonists) stimulates the immune response in the #dog 🐶🐩, reducing the cancerous mass by up to 50% and increasing the survival time by 32 weeks. To be continued https://t.co/wWLaoW
RT @CancerCureNow: Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma https://t.co/6MYAJHXPaB
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma https://t.co/6MYAJHXPaB
RT @VivekSubbiah: 🔺INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/Oy759FQrM8
Intratumoral delivery of sting agonist results in clinical responses in canine #glioblastoma: https://t.co/3wsdjMuTqZ @HeimbergerAmy @CraigHorbinski @NeurosurgeryNM @LurieCancer
RT @VivekSubbiah: 🔺INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/Oy759FQrM8
🔺INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/Oy759FQrM8
RT @CCR_AACR: Boudreau et al study the effect of IACS-8779, a small-molecule STING agonist, in dogs with #glioblastoma and find it is well—…
Boudreau et al study the effect of IACS-8779, a small-molecule STING agonist, in dogs with #glioblastoma and find it is well—tolerated to a dose of 15µg. Higher doses were associated with radiographic responses. https://t.co/4Ef8G0Bbs1 https://t.co/pZdbM5i
RT @NeurosurgeryNM: Intratumoral delivery of sting agonist results in clinical responses in canine #glioblastoma https://t.co/89zeukcsMj @C…
Intratumoral delivery of sting agonist results in clinical responses in canine #glioblastoma https://t.co/89zeukcsMj @CraigHorbinski @HeimbergerAmy
RT @recherche_anima: 🙏🤞 #Glioblastome: un protocole d'immunothérapie (injection intra-tumorale d'agonistes de STING) stimule la réponse imm…
RT @recherche_anima: 🙏🤞 #Glioblastome: un protocole d'immunothérapie (injection intra-tumorale d'agonistes de STING) stimule la réponse imm…
🙏🤞 #Glioblastome: un protocole d'immunothérapie (injection intra-tumorale d'agonistes de STING) stimule la réponse immunitaire chez le #chien 🐶🐩, réduisant la masse cancéreuse jusqu'à 50% et augmentant la durée de survie de 32 semaines. A suivre https://
INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/n92Xmvlicw
8月25日 CLINICAL CANCER RESEARCH 膠芽腫のイヌにSTING agonistを注射する治験(第I相)の結果 https://t.co/tbvSPoL2CM 紹介記事 https://t.co/u1xHr0nuEa 有効性を確認する治験ではないと思います。 STING agonist-1(G10) は「人間には使用しないでください」
RT @oncologiavet: Intratumoral delivery of STING agonist results in clinical responses in canine glioblastoma. https://t.co/EnyNUzLK5f
Intratumoral delivery of STING agonist results in clinical responses in canine glioblastoma. https://t.co/EnyNUzLK5f
RT @HeimbergerAmy: STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bp…
New canine paper! INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/4ctgJXs8lp
RT @HeimbergerAmy: STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bp…
New article: INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/WIdHtNR1kQ #melanoma #oncology https://t.co/VhAFYSSIKA
INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/epYCFmh3NV
RT @HeimbergerAmy: STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bp…
INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA https://t.co/SeqAXW1JzK @tamuvetmed
RT @HeimbergerAmy: STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bp…
RT @HeimbergerAmy: STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bp…
RT @HeimbergerAmy: STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bp…
STING agonists demonstrate signals of response in dogs with spontaneously arising glioblastoma @CCR_AACR https://t.co/bpxefvllHl https://t.co/KrVSISZaWL